About Prof. Rutka:
Prof. Dr. James T. Rutka, MD, PhD, FRCSC, FACS, FAAP, FAANS
Based in Toronto, Ontario, Prof. Rutka is a world-reknown neuro-surgeon and researcher in neuro-oncology. He is director of the Arthur and Sonia Labatt Brain Tumour Research Centre at the Hospital for Sick Children in Toronto, Canada.
His research focuses on the invasive properties of malignant glioma, the most common and most aggressive primary brain tumour in adults.
Glioma invasion into the surrounding brain parenchyma is a leading cause of tumour recurrence and treatment failure. Previous work in Prof.
Rutka’s laboratory has identified alterations in the expression of upstream regulators of GTPases known as Guanine nucleotide Exchange Factors or GEFs. Cytoskeletal GTPases play critical roles in cell motility and migration. Prof. Rutka’s lab is now developing a system to target these proteins in glioma. In collaboration with the Sunnybrook Health Sciences Centre and the University of Toronto Institute of Biomaterials and Biomedical Engineering, his team is designing a nanoparticle based delivery system as a novel approach to treat gliomas.
An inauguration in the presence of the Minister of Health, Mars Di Bartolomeo and Son Altesse Royale La Grande-Duchesse Maria Térésa will be held on Thursday, November 29, 2012 at 1.00pm in front of the Amphitheater of the CHL and in the presence of the media.
Read the press invitation (French version)
On Tuesday 23.10.2012 Wayne A. Madden, the president of Lions International (headquarters in Oak Brook, Illinois, USA) together with the Minister of Health Mars di Bartolomeo has paid an official visit to the World Health Organisation Reference Center for the European Region in Luxembourg located at the Department of Immunology / CRP-Santé, to learn about the progress of the worldwide MEASLES ELIMINATION INITIATIVE. One of the most important world-wide activities of the LIONS INTERNATIONAL is its contribution to and participation in the MEASLES ELIMINATION INITIATIVE of the World Health Organisation (WHO). The MEASLES ELIMINATION INITIATIVE is a consortium of international organisations including e.g. UNICEF, the American Red Cross, the Bill and Melinda Gates Foundation, the United Nations Foundation and others which fund under the auspices of the WHO the eradication of measles and (congenital) rubella throughout the world. LIONS INTERNATIONAL is one of the prominent players in this consortium. To reach the target of eradicating measles, the WHO relies on a world-wide Network of National Laboratories, essentially one in each country of the world. These National Laboratories are supported by Regional Reference Laboratories on each continent. The Department of Immunology , CRP-Santé/LNS in Luxembourg is a Regional Reference Center responsible for 21 countries in Europe and the New Independent States (the former Soviet Republics). In addition, the Department of Immunology, CRP-Santé/LNS in Luxembourg is one of the WHO’s three Collaborating Centers for Research on Measles. Thus, the Department of Immunology is a very prominent player in the Measles Initiative.